REPLIGEN CORP Accrued Liabilities and Other Liabilities
REPLIGEN CORP (RGEN) had Accrued Liabilities and Other Liabilities of $8.74 million as of 2013-06-30, per its 10-Q filed 2013-08-07.
Discontinued › Notes › Payables and Accruals
us-gaap:AccruedLiabilitiesAndOtherLiabilities · last filed 2013-08-07
- 2013-06-30: Accrued Liabilities and Other Liabilities $8.74M.
- 2013-03-31: Accrued Liabilities and Other Liabilities $6.99M.
- 2012-12-31: Accrued Liabilities and Other Liabilities $8.30M.
- 2011-12-31: Accrued Liabilities and Other Liabilities $6.04M.
| Period end | Accrued Liabilities and Other Liabilities |
|---|---|
| 2013-06-30 | $8.74M 10-Q · filed 2013-08-07 |
| 2013-03-31 | $6.99M 10-Q · filed 2013-05-07 |
| 2012-12-31 | $8.30M 10-Q · filed 2013-08-07 |
| 2011-12-31 | $6.04M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |